التفاصيل البيبلوغرافية
العنوان: |
Exploring LGR5 as a prognostic marker of extrahepatic cholangiocarcinoma: insights from expression analysis and clinical correlations. |
المؤلفون: |
Tamada, Hisashi, Uehara, Takeshi, Yoshizawa, Takahiro, Iwaya, Mai, Asaka, Shiho, Nakajima, Tomoyuki, Kamakura, Masato, Ota, Hiroyoshi |
المصدر: |
Diagnostic Pathology; 8/28/2024, Vol. 19 Issue 1, p1-7, 7p |
مصطلحات موضوعية: |
NUCLEIC acid hybridization, GENE expression, CANCER stem cells, IN situ hybridization, OVERALL survival |
مستخلص: |
Background: Leucine-rich repeat-containing G protein-coupled receptor 5 (LGR5) is a cancer stem cell (CSC) marker of colorectal cancer and may be a CSC marker of other cancer types. Few studies have been conducted on LGR5 expression in extrahepatic cholangiocarcinoma (ECC). Methods: We analyzed LGR5 expression using RNAscope, a highly sensitive RNA in situ hybridization technique. Fifty-three ECCs were selected from the medical archives at Shinshu University Hospital and analyzed using a tissue microarray. LGR5 expression levels were divided into expression and no expression groups. LGR5 expression and clinicopathological characteristics were analyzed. Results: Among 25 cases, no LGR5-positive dots were identified. Among 28 cases, some LGR5-positive dots were observed in carcinoma cells, together with a wide range of LGR5-positive cells. LGR5 expression was conspicuous in glandular duct formations. Well- to moderately differentiated types showed significantly higher LGR5 expression than the poorly differentiated type (p = 0.0268). LGR5 expression was associated with good overall survival (p = 0.0219) and good disease-free survival (DFS) (p = 0.0228). High LGR5 expression was associated with well- to moderately-differentiated types, indicating a favorable prognosis. In terms of DFS, multivariate analysis showed that high LGR5 expression was an independent favorable prognostic factor (p = 0.0397). Conclusions: These findings suggest that LGR5 is a promising, novel prognostic marker. [ABSTRACT FROM AUTHOR] |
|
Copyright of Diagnostic Pathology is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
قاعدة البيانات: |
Complementary Index |